Highlights LENSAR, Inc.

Equities

LNSR

US52634L1089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-09 pm EDT			5-day change	1st Jan Change
4.18 ^USD	-5.43%		-3.02%	+19.09%

May. 09	LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Transcript : LENSAR, Inc., Q1 2024 Earnings Call, May 09, 2024

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Earnings Flash (LNSR) LENSAR Reports Q1 Revenue $10.6M	May. 09	MT
LENSAR, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 04	CI
LENSAR, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 04	CI
Earnings Flash (LNSR) LENSAR Posts Q4 Revenue $12.1M	Mar. 04	MT
LENSAR, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (LNSR) LENSAR Reports Q3 Revenue $9.8M	Nov. 09	MT
LENSAR, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Earnings Flash (LNSR) LENSAR Reports Q2 Revenue $12M	23-08-09	MT
Lensar, Inc. Reports Adoption of Ally System in Multi-Center Ophthalmology Groups	23-07-24	CI
Earnings Flash (LNSR) LENSAR Reports Q1 Revenue $8.3M, vs. Street Est of $9.1M	23-05-15	MT
LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Earnings Flash (LNSR) LENSAR Reports Q4 Revenue $10.2M, vs. Street Est of $10M	23-03-16	MT
LENSAR, Inc. Provides Revenue Guidance for the Fiscal 2023	23-03-16	CI
LENSAR, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-16	CI
LENSAR, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-16	CI
LENSAR, Inc. Announces Revenue Results for the Quarter and Year Ended December 31, 2022	23-02-14	CI
LENSAR, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Earnings Flash (LNSR) LENSAR Posts Q3 Revenue $7.7M, vs. Street Est of $7.9M	22-11-09	MT
LENSAR Applies for EU Certification of ALLY Adaptive Cataract Treatment System	22-09-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights LENSAR, Inc.

Equities

LNSR

US52634L1089

Highlights

Filters